Last reviewed · How we verify
Yuxi Walvax MPV ACYW® vaccine
Yuxi Walvax MPV ACYW® vaccine is a Biologic drug developed by Walvax Biotechnology Co., Ltd.. It is currently FDA-approved.
At a glance
| Generic name | Yuxi Walvax MPV ACYW® vaccine |
|---|---|
| Sponsor | Walvax Biotechnology Co., Ltd. |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yuxi Walvax MPV ACYW® vaccine CI brief — competitive landscape report
- Yuxi Walvax MPV ACYW® vaccine updates RSS · CI watch RSS
- Walvax Biotechnology Co., Ltd. portfolio CI
Frequently asked questions about Yuxi Walvax MPV ACYW® vaccine
What is Yuxi Walvax MPV ACYW® vaccine?
Yuxi Walvax MPV ACYW® vaccine is a Biologic drug developed by Walvax Biotechnology Co., Ltd..
Who makes Yuxi Walvax MPV ACYW® vaccine?
Yuxi Walvax MPV ACYW® vaccine is developed and marketed by Walvax Biotechnology Co., Ltd. (see full Walvax Biotechnology Co., Ltd. pipeline at /company/walvax-biotechnology-co-ltd).
What development phase is Yuxi Walvax MPV ACYW® vaccine in?
Yuxi Walvax MPV ACYW® vaccine is FDA-approved (marketed).